BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Auriga Laboratories, Inc. 

5555 Triangle Parkway
Suite 300
Norcross  Georgia  30092  U.S.A.
Phone: 877-287-4428 Fax: 678-282-1700


SEARCH JOBS


Industry
Pharmaceutical






 Company News
A.T.S. Pharmaceuticals, a Division of Auriga Laboratories, Inc. (ARGA.OB), Launches Breze(TM) Pads for the Topical Treatment of Acne Vulgaris 4/1/2008 8:53:44 AM    More...
Auriga Laboratories, Inc. (ARGA.OB) Announces the Launch of Extendryl®(R) PEM and Extendryl(R) GCP 3/21/2008 8:48:38 AM    More...
Auriga Laboratories, Inc. (ARGA.OB) Announces FDA Approval of Liquadd(TM) Oral Solution for the Treatment of ADHD and Upcoming Product Launch 3/10/2008 6:46:37 AM    More...
Frank R. Greico Named CEO of Auriga Laboratories, Inc. (ARGA.OB) 1/24/2008 3:44:56 PM    More...
Auriga Laboratories, Inc. (ARGA.OB) Signs Co-Promotion Agreement With MiddleBrook Pharmaceuticals, Inc. for Keflex(R) 750 mg 1/7/2008 10:02:03 AM    More...
Auriga Laboratories, Inc. (ARGA.OB) Obtains Rights to Market and Sell a New Product Indicated for the Treatment of ADHD 12/3/2007 11:56:36 AM    More...
Auriga Laboratories, Inc. (ARGA.OB) Issues Third Quarter 2007 Dispensed Prescriptions Update on Promoted Products 11/2/2007 11:36:46 AM    More...
Auriga Laboratories, Inc. (ARGA.OB)'s Continues Sale Force Expansion to Position for 2008 10/23/2007 6:34:42 AM    More...
Auriga Laboratories, Inc. (ARGA.OB) to Announce Third Quarter Financial Results on Thursday, November 8th 10/16/2007 11:01:58 AM    More...
Auriga Laboratories, Inc. (ARGA.OB) To Present at America's Growth Capital's 4th Annual Emerging Growth Conference on Thursday, September 20th 9/10/2007 11:38:06 AM    More...
12345678

//-->